-
Smarter Starts, Stronger Trials: How Data is Driving Faster Site Activation
Jul 11 | Clinical Research News | Feasibility, site selection, and study startup remain some of the most time-consuming and unpredictable phases of drug development. They are also tightly interconnected, making even small delays or inefficiencies during this period especially impactful, rippling across a study’s timeline and budget and affecting site relationships and patient access. More -
Scope of Things: Pragmatic Trials’ Growing Importance
Jul 09 | Clinical Research News | The growing importance of pragmatic clinical trials in healthcare research cannot be overstated. In the most recent episode of the Scope of Things podcast, host Deborah Borfitz speaks with Bethany Kwan, University of Colorado Anschutz Medical Campus, and Heather Smyth, Colorado School of Public Health. Together they explore the fundamental distinctions between traditional clinical trials and pragmatic research approaches, uncovering why this methodology is experiencing such significant growth in modern healthcare research. More -
ICH E6(R3) Guidance: Elevating Trials through Collaboration
Jul 03 | Clinical Research News | After 15 years of development, Stanford University's Tom Soh is preparing to take his biosensor technology from laboratory rats to human volunteers. The device, which can continuously monitor molecules in flowing blood for up to seven days, represents a potential paradigm shift in clinical medicine. More -
Stanford's Blood Flow Biosensor Heads to Human Trials
Jul 02 | Clinical Research News | After 15 years of development, Stanford University's Tom Soh is preparing to take his biosensor technology from laboratory rats to human volunteers. The device, which can continuously monitor molecules in flowing blood for up to seven days, represents a potential paradigm shift in clinical medicine. More -
Walgreens ‘Built the Vessel’ for Making Clinical Trials a Care Option
Jul 01 | Clinical Research News | In the span of three years, Walgreens—an integral part of communities across the U.S. for well over a century—has positioned itself as a key player in the clinical trial ecosystem highlighted by more than 35 biopharma partnerships and the engagement of over 17 million customers participating in industry-sponsored studies. The thesis that co-locating trials where patients are “actually works." More -
Follow the Money: Migraine Therapy, Reducing Trial Failure, More
Jun 25 | Clinical Research News | Salvia plans to further develop MySalvia Therapy in a multi-center, double-blind, sham-controlled study for people with chronic migraine; Vivodyne plans to scale its robotics+AI approach to testing on thousands of lab-grown, fully-functional human tissues, which aim to reduce human clinical trial failure; and more. More -
Veeva, Sarah Cannon Research Institute Collaboration, City of Hope Receives Grant, More
Jun 24 | Clinical Research News | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more. More -
Beyond Vitals: How Patient-Generated Data is Driving AI’s Healthcare Transformation
Jun 20 | Clinical Research News | In recent years, AI in healthcare has attracted growing interest and investment, with new roles like Chief AI Officer and AI-specific policies underscoring its transformative potential. However, one critical factor is often overlooked: the quality of the data used to train AI algorithms. While AI’s impact is undeniable, its effectiveness depends on the depth, diversity, and granularity of the data it processes. More -
Genetic Testing Transforms Medication Prescribing for Better Patient Outcomes
Jun 18 | Clinical Research News | The UK National Health Service’s PROGRESS trial has achieved remarkable clinical success, with one in four patients having their prescriptions adjusted based on genetic test results, leading to safer and more effective treatments. The PROGRESS trial’s interim results reveal that 95% of the 500 patients tested carried genetic variants that directly influence how they metabolize common medications. More -
AI Agent Speeds Up Trials with Instant, Personalized Participant Interactions
Jun 17 | Clinical Research News | An artificial intelligence (AI) agent known as Grace is bringing clinical trials some much-needed speed and cost reduction and delivering more personalized, on-demand digital experiences for participants. Developed by fast-growing Grove AI, Grace has over the past year powered more than 50 phase 2 and 3 trials involving over 500,000 interactions with would-be and enrolled trial participants. More


The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.